Ingested (oral) alpha-MSH inhibits acute EAE

Journal of Neuroimmunology

Volumn 193, Issue 1-2, 2008, Pages 106-112

  Brod, Staley A ^a   Hood, Zachary M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Alpha MSH; CNS chemokines; EAE; Oral therapy

Indexed keywords

ALPHA INTERMEDIN; INTERLEUKIN 12P70; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1GAMMA; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; INFLAMMATION; LYMPHOCYTE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TH1 CELL; TH2 CELL;

ACUTE DISEASE; ADMINISTRATION, ORAL; ALPHA-MSH; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHEMOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GLYCOPROTEINS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS;

EID: 37749026839     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.10.026     Document Type: Article

References (38)

1. Alvord E.C., Shaw C.M., Huby S., and Kies M.K. Encephalitogen-induced inhibition of experimental allergic encephalomyelitis: prevention, suppression, and therapy. Ann. N. Y. Acad. Sci. 122 (1965) 333-345
2. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., Aiuti A., and Springer T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184 (1996) 1101-1109
3. Brod S., Darcan S., Malone M., Pappolla M., and Nelson L. Ingested IFN-α suppresses IDDM in the NOD mouse. Diabetologia 41 (1998) 1227-1232
4. Brod S., Orlander P., Lavis V., Brosnan P., Hardin D., Henninger E., Nyugen M., and Riley W. Ingested IFN-α prolongs the "honeymoon" period in newly diagnosed type I diabetes mellitus. J. Interferon Cyt Res. 21 (2001) 1021-1030
5. Brod S.A., and Burns D.K. Suppression of relapsing experimental autoimmune encephalomyelitis in the SJL/J mouse by oral administration of type I interferons. Neurology 44 (1994) 1144-1148
6. Brod S.A., and Hood Z. Ingested (oral) SIRS peptide 1-21 inhibits acute EAE by inducing Th(2)-like cytokines. J. Neuroimmunol. 183 (2007) 89-95
7. Brod S.A., Kerman R.H., Nelson L.D., Marshall Jr. G.D., Henninger E.M., Khan M., Jin R., and Wolinsky J.S. Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosis. Mult. Scler. 3 (1997) 1-7
8. Brod S.A., and Khan M. Oral administration of IFN-alpha is superior to subcutaneous administration of IFN-alpha in the suppression of chronic relapsing experimental autoimmune encephalomyelitis. J. Autoimmun. 9 (1996) 11-20
9. Brod S.A., Khan M., Kerman R.H., and Pappolla M. Oral administration of human or murine interferon alpha suppresses relapses and modifies adoptive transfer in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58 (1995) 61-69
10. Brod S.A., Khan M., Nelson L.D., Decuir B., Malone M., and Henninger E. Adoptive transfer from interferon-alpha-fed mice is associated with inhibition of active experimental autoimmune encephalomyelitis by decreasing recipient tumor necrosis factor-alpha secretion. J Immunother. 23 (2000) 235-245
11. Brod S.A., Lindsey J.W., Vriesendorp F.S., Ahn C., Henninger E., Narayana P.A., and Wolinsky J.S. Ingested IFN-alpha: results of a pilot study in relapsing-remitting MS. Neurology 57 (2001) 845-852
12. Brod S.A., Nelson L., Jin R., and Wolinsky J.S. Ingested interferon alpha induces Mx mRNA. Cytokine 11 (1999) 492-499
13. Buggy J.J. Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem J 331 Pt 1 (1998) 211-216
14. Campbell I.K., Rich M.J., Bischof R.J., and Hamilton J.A. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukoc. Biol. 68 (2000) 144-150
15. Feuer C., Prentice D.E., and Cammisuli S. Chronic relapsing experimental allergic encephalomyelitis in the lewis rat. J. Neuroimmunol. 10 (1985) 159-166
16. Hamilton N.H., Banyer J.L., Hapel A.J., Mahalingam S., Ramsay A.J., Ramshaw I.A., and Thomson S.A. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE). Scand. J. Immunol. 55 (2002) 171-177
17. Issazadeh S., Mustafa M., Ljungdahl A., Hojeberg B., Dagerlind A., Elde R., and Olsson T. Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J. Neurosci. Res. 40 (1995) 579-590
18. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., Ratajczak J., and Ratajczak M.Z. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23 (2005) 879-894
19. Luger T.A., Scholzen T.E., Brzoska T., and Bohm M. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann. N. Y. Acad. Sci. 994 (2003) 133-140
20. Lyons J.A., Zhao M.L., and Fritz R.B. Pathogenesis of acute passive murine encephalomyelitis II. Th1 phenotype of the inducing population is not sufficient to cause disease. J. Neuroimmunol. 93 (1999) 26-36
21. Malefyt R., Haanen J., Spits H., Roncarolo M.-G., te Velde A., Figdor C., and de Vries J. IL-10 and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via downregulation of class II MHC expression. J. Exp. Med. 174 (1991) 915-924
22. Manna S.K., and Aggarwal B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol. 161 (1998) 2873-2880
23. Marusic S., Miyashiro J.S., Douhan III J., Konz R.F., Xuan D., Pelker J.W., Ling V., Leonard J.P., and Jacobs K.A. Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice. Neurosci. Lett. 332 (2002) 185-189
24. McColl S.R., Mahalingam S., Staykova M., Tylaska L.A., Fisher K.E., Strick C.A., Gladue R.P., Neote K.S., and Willenborg D.O. Expression of rat I-TAC/CXCL11/SCYA11 during central nervous system inflammation: comparison with other CXCR3 ligands. Lab. Invest. 84 (2004) 1418-1429
25. Mohamadzadeh M., Poltorak A.N., Bergstressor P.R., Beutler B., and Takashima A. Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family. J. Immunol. 156 (1996) 3102-3106
26. Monney L., Sabatos C.A., Gaglia J.L., Ryu A., Waldner H., Chernova T., Manning S., Greenfield E.A., Coyle A.J., Sobel R.A., Freeman G.J., and Kuchroo V.K. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415 (2002) 536-541
27. Offner H., Subramanian S., Wang C., Afentoulis M., Vandenbark A.A., Huan J., and Burrows G.G. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J. Immunol. 175 (2005) 4103-4111
28. Papadakis K.A., Prehn J., Nelson V., Cheng L., Binder S.W., Ponath P.D., Andrew D.P., and Targan S.R. The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J. Immunol. 165 (2000) 5069-5076
29. Pellegrini P., Berghella A.M., Contasta I., and Adorno D. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Transpl. Immunol. 12 (2003) 49-61
30. Poznansky M.C., Olszak I.T., Foxall R., Evans R.H., Luster A.D., and Scadden D.T. Active movement of T cells away from a chemokine. Nat. Med. 6 (2000) 543-548
31. Raine C.S., and Stone S.H. Animal models for multiple sclerosis: chronic experimental allergic encephalomyelitis in inbred guinea pigs. N.Y. State J. Med. 77 (1977) 1693-1696
32. Renno T., Krakowski M., Piccirillo C., Lin L., and Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154 (1995) 944-953
33. Rossi F.M., Degan M., Mazzocut-Zecchin L., Di Francia R., Aldinucci D., Pinto A., and Gattei V. CD30L up-regulates CD30 and IL-4 expression by T cells. FEBS Lett. 508 (2001) 418-422
34. Taylor A.W. Modulation of regulatory T cell immunity by the neuropeptide alpha-melanocyte stimulating hormone. Cell Mol Biol (Noisy-le-grand) 49 (2003) 143-149
35. Tompkins S.M., Padilla J., Dal Canto M.C., Ting J.P., Van Kaer L., and Miller S.D. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168 (2002) 4173-4183
36. Wisnewski H.M., and Keith A.B. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann. Neurol. 1 (1977) 144-148
37. Yin P., Luby T.M., Chen H., Etemad-Moghadam B., Lee D., Aziz N., Ramstedt U., and Hedley M.L. Generation of expression constructs that secrete bioactive alphaMSH and their use in the treatment of experimental autoimmune encephalomyelitis. Gene Ther. 10 (2003) 348-355
38. Young D.A., Lowe L.D., Booth S.S., Whitters M.J., Nicholson L., Kuchroo V.K., and Collins M. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis. J. Immunol. 164 (2000) 3563-3572